ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/09/04 | 2,677 | 2,765 | 2,661 | 2,753 | +26 | +1% | 1,535,600 |
2020/09/03 | 2,650 | 2,745 | 2,617 | 2,727 | +38 | +1.4% | 1,636,800 |
2020/09/02 | 2,751 | 2,811 | 2,635 | 2,689 | -122 | -4.3% | 2,979,700 |
2020/09/01 | 2,514 | 2,828 | 2,510 | 2,811 | +311 | +12.4% | 4,226,100 |
2020/08/31 | 2,454 | 2,516 | 2,411 | 2,500 | +145 | +6.2% | 1,575,500 |
2020/08/28 | 2,490 | 2,537 | 2,292 | 2,355 | -114 | -4.6% | 3,129,300 |
2020/08/27 | 2,509 | 2,610 | 2,448 | 2,469 | -41 | -1.6% | 3,028,900 |
2020/08/26 | 2,470 | 2,560 | 2,415 | 2,510 | +22 | +0.9% | 5,071,600 |
2020/08/25 | 2,586 | 2,689 | 2,462 | 2,488 | -132 | -5% | 9,188,000 |
2020/08/24 | 2,214 | 2,654 | 2,205 | 2,620 | +453 | +20.9% | 9,197,300 |
2020/08/21 | 2,123 | 2,242 | 2,068 | 2,167 | +42 | +2% | 6,838,700 |
2020/08/20 | 2,317 | 2,499 | 2,103 | 2,125 | -13 | -0.6% | 15,085,600 |
2020/08/19 | 2,138 | 2,138 | 2,138 | 2,138 | +400 | +23% | 197,800 |
2020/08/18 | 1,738 | 1,738 | 1,738 | 1,738 | +300 | +20.9% | 106,300 |
2020/08/17 | 1,485 | 1,523 | 1,427 | 1,438 | -72 | -4.8% | 1,266,400 |
2020/08/14 | 1,483 | 1,523 | 1,470 | 1,510 | +41 | +2.8% | 1,077,300 |
2020/08/13 | 1,479 | 1,491 | 1,453 | 1,469 | +4 | +0.3% | 517,300 |
2020/08/12 | 1,451 | 1,482 | 1,440 | 1,465 | +1 | +0.1% | 534,800 |
2020/08/11 | 1,430 | 1,464 | 1,407 | 1,464 | +62 | +4.4% | 598,200 |
2020/08/07 | 1,380 | 1,405 | 1,358 | 1,402 | +12 | +0.9% | 429,000 |
2020/08/06 | 1,440 | 1,440 | 1,373 | 1,390 | -39 | -2.7% | 556,700 |
2020/08/05 | 1,410 | 1,447 | 1,398 | 1,429 | +3 | +0.2% | 495,200 |
2020/08/04 | 1,379 | 1,442 | 1,369 | 1,426 | +72 | +5.3% | 731,700 |
2020/08/03 | 1,334 | 1,360 | 1,321 | 1,354 | +30 | +2.3% | 527,300 |
2020/07/31 | 1,355 | 1,368 | 1,316 | 1,324 | -57 | -4.1% | 590,400 |
2020/07/30 | 1,370 | 1,403 | 1,350 | 1,381 | +26 | +1.9% | 750,700 |
2020/07/29 | 1,397 | 1,415 | 1,346 | 1,355 | -68 | -4.8% | 1,028,200 |
2020/07/28 | 1,467 | 1,493 | 1,410 | 1,423 | -28 | -1.9% | 673,800 |
2020/07/27 | 1,463 | 1,497 | 1,449 | 1,451 | -52 | -3.5% | 600,400 |
2020/07/22 | 1,512 | 1,515 | 1,465 | 1,503 | -22 | -1.4% | 542,700 |
2020/07/21 | 1,518 | 1,542 | 1,500 | 1,525 | +15 | +1% | 428,300 |
2020/07/20 | 1,484 | 1,525 | 1,477 | 1,510 | +25 | +1.7% | 765,800 |
2020/07/17 | 1,542 | 1,562 | 1,476 | 1,485 | -60 | -3.9% | 1,115,100 |
2020/07/16 | 1,600 | 1,600 | 1,535 | 1,545 | -46 | -2.9% | 598,500 |
2020/07/15 | 1,592 | 1,613 | 1,576 | 1,591 | +9 | +0.6% | 457,600 |
2020/07/14 | 1,590 | 1,619 | 1,560 | 1,582 | -34 | -2.1% | 693,000 |
2020/07/13 | 1,570 | 1,621 | 1,535 | 1,616 | +47 | +3% | 657,200 |
2020/07/10 | 1,575 | 1,623 | 1,565 | 1,569 | -5 | -0.3% | 924,800 |
2020/07/09 | 1,682 | 1,690 | 1,572 | 1,574 | -108 | -6.4% | 1,453,700 |
2020/07/08 | 1,618 | 1,700 | 1,591 | 1,682 | +67 | +4.1% | 1,450,200 |
2020/07/07 | 1,556 | 1,617 | 1,541 | 1,615 | +63 | +4.1% | 976,100 |
2020/07/06 | 1,520 | 1,562 | 1,479 | 1,552 | +4 | +0.3% | 898,800 |
2020/07/03 | 1,510 | 1,582 | 1,502 | 1,548 | +53 | +3.5% | 846,800 |
2020/07/02 | 1,567 | 1,577 | 1,490 | 1,495 | -83 | -5.3% | 1,415,100 |
2020/07/01 | 1,650 | 1,660 | 1,570 | 1,578 | -71 | -4.3% | 1,156,400 |
2020/06/30 | 1,633 | 1,696 | 1,582 | 1,649 | +52 | +3.3% | 1,116,800 |
2020/06/29 | 1,666 | 1,690 | 1,595 | 1,597 | -107 | -6.3% | 1,084,100 |
2020/06/26 | 1,678 | 1,705 | 1,652 | 1,704 | +22 | +1.3% | 818,800 |
2020/06/25 | 1,704 | 1,758 | 1,660 | 1,682 | -72 | -4.1% | 1,674,300 |
2020/06/24 | 1,720 | 1,773 | 1,708 | 1,754 | +31 | +1.8% | 753,900 |
1001~
1050
件表示中 / 3553件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.21倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
科研薬 | 386,000円 | +22.8% | +113.0% | 4.92% | 10.29倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 316,000円 | +14.7% | -21.6% | 1.90% | 12.35倍 | 1.00倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム